Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133483) titled 'Efficacy and safety of LN016 sustained-release gel for postoperative analgesia after abdominal surgery: a multicenter, randomized, double-blind, positive drug parallel controlled clinical trial' on Sept. 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Third Xiangya Hospital Central South University

Condition: Pain after abdominal surgery

Intervention: Stage 2 : LN016 high-dose group:LN016 sustained-release gel, 6.8 mL (containing 200mg bupivacaine and 6mg meloxicam) Stage 2 : LN016 low-dose group:LN016 sustained-release gel, 5.1 mL (containing 150mg bupivacaine and 4.5mg mel...